东瑞制药(02348)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02348 东瑞制药

未开盘 08-13 16:08:25

1.380

-0.010

-0.72%

最高1.390	最低1.360	成交量84.20万
今开1.390	昨收1.390	日振幅2.16%
总市值20.74亿	流通市值20.74亿	总股本15.03亿
成交额115.72万	换手率0.06%	流通股本15.03亿
市净率0.57	ROE18.19%	每股收益0.41
52周最高1.470	52周最低0.999	市盈率3.36
股息0.06	股息收益率0.05	ROA3.31%

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02348","market":"HK","secType":"STK","nameCN":"东瑞制药","latestPrice":1.38,"timestamp":1755072505653,"preClose":1.39,"halted":0,"volume":842000,"delay":0,"floatShares":1503000000,"shares":1503000000,"eps":0.4103960076929115,"marketStatus":"未开盘","change":-0.01,"latestTime":"08-13 16:08:25","open":1.39,"high":1.39,"low":1.36,"amount":1157220,"amplitude":0.021583,"askPrice":1.39,"askSize":140000,"bidPrice":1.36,"bidSize":124000,"shortable":0,"etf":0,"ttmEps":0.41016534373184704,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1755135000000},"marketStatusCode":0,"adr":0,"listingDate":1057852800000,"exchange":"SEHK","adjPreClose":1.39,"dividendRate":0.046704,"openAndCloseTimeList":[[1755048600000,1755057600000],[1755061200000,1755072000000]],"volumeRatio":2.149218,"lotSize":4000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02348","defaultTab":"news","newsList":[{"id":"2558809652","title":"东瑞制药8月22日举行董事会会议考虑及批准中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2558809652","media":"格隆汇资讯","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558809652?lang=zh_cn&edition=full","pubTime":"2025-08-11 17:42","pubTimestamp":1754905350,"startTime":"0","endTime":"0","summary":"格隆汇8月11日丨东瑞制药(02348.HK)宣布，公司将于2025年8月22日(星期五)举行董事会会议，藉以(其中包括)考虑及批准公司及其附属公司截至2025年6月30日止六个月之中期业绩及其刊发，以及考虑派付中期股息(如有)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081117423797409294&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081117423797409294&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02348"],"gpt_icon":0},{"id":"2555912886","title":"东瑞制药(02348)：胡硕获委任为非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2555912886","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555912886?lang=zh_cn&edition=full","pubTime":"2025-07-31 18:15","pubTimestamp":1753956957,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东瑞制药(02348)发布公告，胡硕先生已获委任为公司非执行董事，自2025年8月1日起生效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1324255.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02348","BK1191"],"gpt_icon":0},{"id":"2553552447","title":"东瑞制药盘中异动 快速上涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553552447","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553552447?lang=zh_cn&edition=full","pubTime":"2025-07-21 09:37","pubTimestamp":1753061870,"startTime":"0","endTime":"0","summary":"2025年07月21日早盘09时37分，东瑞制药股票出现异动，股价快速拉升5.19%。截至发稿，该股报1.420港元/股，成交量14.4万股，换手率0.01%，振幅4.44%。东瑞制药股票所在的药品行业中，整体跌幅为0.07%。其相关个股中，精优药业、金嗓子、东瑞制药涨幅较大，振幅较大的相关个股有精优药业、德琪医药-B、李氏大药厂，振幅分别为10.23%、6.26%、6.25%。成药部从事制造及销售成药业务,包括抗生素制剂药及非抗生素制剂药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072109375097addaf7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072109375097addaf7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02348","BK1191"],"gpt_icon":0},{"id":"2552486457","title":"东瑞制药盘中异动 股价大涨5.34%报1.380港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552486457","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552486457?lang=zh_cn&edition=full","pubTime":"2025-07-18 14:56","pubTimestamp":1752821789,"startTime":"0","endTime":"0","summary":"2025年07月18日下午盘14时56分，东瑞制药股票出现波动，股价快速拉升5.34%。截至发稿，该股报1.380港元/股，成交量99.6万股，换手率0.07%，振幅5.34%。资金方面，该股资金流入73.64万港元，流出45.796万港元。东瑞制药股票所在的药品行业中，整体涨幅为0.80%。其相关个股中，德琪医药-B、金嗓子、精优药业涨幅较大，振幅较大的相关个股有泰凌医药、兴科蓉医药、天大药业，振幅分别为22.22%、21.12%、14.37%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071814562997aac7a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071814562997aac7a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02348"],"gpt_icon":0},{"id":"2551979309","title":"东瑞制药盘中异动 大幅拉升5.56%报1.330港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551979309","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551979309?lang=zh_cn&edition=full","pubTime":"2025-07-14 13:09","pubTimestamp":1752469784,"startTime":"0","endTime":"0","summary":"2025年07月14日下午盘13时09分，东瑞制药股票出现波动，股价急速拉升5.56%。截至发稿，该股报1.330港元/股，成交量64.4万股，换手率0.04%，振幅7.94%。资金方面，该股资金流入67.412万港元，流出12.056万港元。东瑞制药股票所在的药品行业中，整体涨幅为1.21%。其相关个股中，泰德医药、天大药业、开拓药业-B涨幅较大，振幅较大的相关个股有开拓药业-B、泰德医药、华控康泰，振幅分别为12.15%、11.68%、10.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071413094497a53622&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071413094497a53622&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02348"],"gpt_icon":0},{"id":"2549532072","title":"精工国际钢结构有限公司增持东瑞制药(02348)1.09亿股 每股作价1.2港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549532072","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549532072?lang=zh_cn&edition=full","pubTime":"2025-07-07 20:37","pubTimestamp":1751891878,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新数据显示，7月3日，精工国际钢结构有限公司增持东瑞制药(02348)1.09亿股，每股作价1.2港元，总金额约为1.308亿港元。增持后最新持股数目为1.09亿股，持股比例为7.24%。本交易涉及其他关联方：长江精工钢结构（集团）股份有限公司","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1314823.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02348"],"gpt_icon":0},{"id":"2546782511","title":"【国药现代：阿奇霉素干混悬剂通过仿制药一致性评价】国药现代公告，公司阿奇霉素干混悬剂通过仿制药质量和疗效一致性评价。阿奇霉素干混悬剂2024年全国公立医疗机构及城市药店销售额为14.75亿元。目前通过一致性评价的企业包括石药集团欧意药业有限公司、宜昌东阳光长江药业股份有限公司、苏州东瑞制药有限公司、海南普利制药股份有限公司等。公司累计研发投入约1737.25万元。本次通过一致性评价有利于产品市场拓展和销售，但业绩影响存在不确定性。","url":"https://stock-news.laohu8.com/highlight/detail?id=2546782511","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546782511?lang=zh_cn&edition=full","pubTime":"2025-06-26 19:08","pubTimestamp":1750936139,"startTime":"0","endTime":"0","summary":"国药现代公告，公司阿奇霉素干混悬剂通过仿制药质量和疗效一致性评价。阿奇霉素干混悬剂2024年全国公立医疗机构及城市药店销售额为14.75亿元。目前通过一致性评价的企业包括石药集团欧意药业有限公司、宜昌东阳光长江药业股份有限公司、苏州东瑞制药有限公司、海南普利制药股份有限公司等。公司累计研发投入约1737.25万元。本次通过一致性评价有利于产品市场拓展和销售，但业绩影响存在不确定性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/26190851327499.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU1226288170.HKD","IE00B543WZ88.USD","LU1993786604.SGD","BK1521","IE00B031HY20.USD","LU0326950275.SGD","IE00BZ08YT58.USD","LU0140636845.USD","BK0020","IE0008369823.USD","BK0082","BK1191","IE00B5MMRT66.SGD","SG9999004220.SGD","LU1951186391.HKD","IE00BZ08YS42.EUR","BK0239","600420","LU1152091168.USD","LU0067412154.USD","LU0072913022.USD","BK0010","02348","01558","LU1152091754.HKD","LU1226288253.USD","IE0008368742.USD","BK1574","LU1226287792.SGD","LU1226287875.USD","LU1807302812.USD","IE00BZ08YR35.GBP","01093","LU1008478684.HKD","LU0501845795.SGD","BK0132","LU0880133367.SGD","LU1960683339.HKD","01477","LU1226287529.USD","BK1515"],"gpt_icon":0},{"id":"2539243944","title":"李其玲增持东瑞制药(02348)6.8万股 每股作价1.17港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539243944","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539243944?lang=zh_cn&edition=full","pubTime":"2025-05-30 15:11","pubTimestamp":1748589079,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，5月28日，李其玲增持东瑞制药(02348)6.8万股，每股作价1.17港元，总金额约为7.956万港元。增持后最新持股数目约为7.09亿股，最新持股比例为47.20%。本交易涉及其他关联方：熊融礼。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1299587.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02348","BK1191"],"gpt_icon":0},{"id":"2538179034","title":"东瑞制药05月26日主力净流出25.4万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2538179034","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538179034?lang=zh_cn&edition=full","pubTime":"2025-05-26 16:15","pubTimestamp":1748247322,"startTime":"0","endTime":"0","summary":"05月26日，东瑞制药股价收平报1.20元，成交金额60.1万元，换手率0.03%，振幅2.50%，量比2.23。东瑞制药今日主力资金净流出25.4万元，上一交易日主力净流出0万元。该股近5个交易日上涨2.56%，主力资金累计净流出25.4万元；近20日主力资金累计净流出25.4万元，其中净流出天数为1日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250526171931a48cc400&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250526171931a48cc400&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02348"],"gpt_icon":0},{"id":"2536685184","title":"李其玲增持东瑞制药(02348)7.6万股 每股作价1.16港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536685184","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536685184?lang=zh_cn&edition=full","pubTime":"2025-05-19 18:58","pubTimestamp":1747652319,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，5月15日，李其玲增持东瑞制药(02348)7.6万股，每股作价1.16港元，总金额约为8.82万港元。增持后最新持股数目约为7.09亿股，最新持股比例为47.19%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1294896.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02348","BK1191"],"gpt_icon":0},{"id":"2531733692","title":"李其玲增持东瑞制药(02348)1.2万股 每股作价1.16港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531733692","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531733692?lang=zh_cn&edition=full","pubTime":"2025-04-29 20:22","pubTimestamp":1745929370,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，4月25日，李其玲增持东瑞制药(02348)1.2万股，每股作价1.16港元，总金额约为1.39万港元。增持后最新持股数目约为7.09亿股，最新持股比例为47.18%。本交易涉及其他关联方：熊融礼。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1287679.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02348","BK1191"],"gpt_icon":0},{"id":"2530242775","title":"东瑞制药2024年净利润5.65亿元 成品药仍为核心支柱","url":"https://stock-news.laohu8.com/highlight/detail?id=2530242775","media":"GPLP犀牛财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530242775?lang=zh_cn&edition=full","pubTime":"2025-04-28 16:55","pubTimestamp":1745830500,"startTime":"0","endTime":"0","summary":"4月24日，东瑞制药发布年报，2024年实现营业收入10.6亿元，同比下降7.9%；实现归母净利润5.65亿元，同比大幅增长73.3%；基本每股收益为0.38元/股。2024年，东瑞制药研发支出为7083万元，同比下降22%，主要聚焦首仿及改良型创新药，年内获批6项专利，新增注射头孢等6个集采中标品规。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428165523974839ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428165523974839ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02348"],"gpt_icon":0},{"id":"2527173516","title":"东瑞制药获李其玲增持4000股 每股作价1.08港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527173516","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527173516?lang=zh_cn&edition=full","pubTime":"2025-04-15 08:12","pubTimestamp":1744675920,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　香港联交所最新资料显示，4月9日，李其玲增持东瑞制药（02348）4000股，每股作价1.08港元，总金额约为4320港元。增持后最新持股数目为7.09亿股，最新持股比例为47.17%。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-04-15/doc-inetfaix4266817.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02348","BK1191"],"gpt_icon":0},{"id":"2527163657","title":"李其玲增持东瑞制药(02348)4000股 每股作价1.08港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527163657","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527163657?lang=zh_cn&edition=full","pubTime":"2025-04-14 20:41","pubTimestamp":1744634511,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，4月9日，李其玲增持东瑞制药(02348)4000股，每股作价1.08港元，总金额约为4320港元。增持后最新持股数目为7.09亿股，最新持股比例为47.17%。本交易涉及其他关联方：熊融礼。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1278390.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02348"],"gpt_icon":0},{"id":"2492512419","title":"主席李其玲增持东瑞制药(02348)18.4万股 每股作价1.2港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492512419","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492512419?lang=zh_cn&edition=full","pubTime":"2024-12-17 20:05","pubTimestamp":1734437100,"startTime":"0","endTime":"0","summary":"香港联交所最新资料显示，12月13日，主席李其玲增持东瑞制药(02348)18.4万股，每股作价1.2港元，总金额为22.08万港元。增持后最新持股数目为7.08亿股，最新持股比例为47.14%。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-12-17/doc-inczurfi4699083.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02348","BK1191"],"gpt_icon":0},{"id":"2488988539","title":"主席李其玲增持东瑞制药(02348)8.8万股 每股作价约1.21港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488988539","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488988539?lang=zh_cn&edition=full","pubTime":"2024-12-03 16:26","pubTimestamp":1733214376,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，11月29日，主席李其玲增持东瑞制药(02348)8.8万股，每股作价1.2132港元，总金额为10.68万港元。增持后最新持股数目为7.07亿股，持股比例为47.08%。本交易涉及其他关联方：熊融礼。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1219621.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02348"],"gpt_icon":0},{"id":"2480327046","title":"东瑞制药盘中异动 快速上涨7.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480327046","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480327046?lang=zh_cn&edition=full","pubTime":"2024-11-04 15:42","pubTimestamp":1730706161,"startTime":"0","endTime":"0","summary":"2024年11月04日临近收盘15时42分，东瑞制药股票出现波动，股价急速上涨7.26%。截至发稿，该股报1.330港元/股，成交量7.6万股，换手率0.01%，振幅8.06%。资金方面，该股资金流入5320港元，流出7.932万港元。东瑞制药股票所在的药品行业中，整体涨幅为0.46%。其相关个股中，信达生物、中国医疗集团、海王英特龙涨幅较大，振幅较大的相关个股有顺腾国际控股、兴科蓉医药、三爱健康集团，振幅分别为22.22%、18.75%、10.94%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104154241a2141202&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104154241a2141202&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02348","BK1191"],"gpt_icon":0},{"id":"2479247918","title":"东瑞制药股价上涨11.20% 市值涨2.34亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479247918","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479247918?lang=zh_cn&edition=full","pubTime":"2024-10-30 14:58","pubTimestamp":1730271483,"startTime":"0","endTime":"0","summary":"2024年10月30日下午盘14时58分，东瑞制药股票出现异动，股价大幅上涨11.20%。截至发稿，该股报1.390港元/股，成交量3.6万股，换手率0.00%，振幅12.00%。资金方面，该股资金流入5560港元，流出3.972万港元。东瑞制药股票所在的药品行业中，整体跌幅为0.56%。其相关个股中，开拓药业-B、艾美疫苗、白花油涨幅较大，振幅较大的相关个股有翰森制药、泰凌医药、德琪医药-B，振幅分别为12.52%、12.12%、11.76%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030145803ab81ead2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030145803ab81ead2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02348","BK1191"],"gpt_icon":0},{"id":"2474315255","title":"东瑞制药盘中异动 大幅跳水6.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474315255","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474315255?lang=zh_cn&edition=full","pubTime":"2024-10-09 10:02","pubTimestamp":1728439365,"startTime":"0","endTime":"0","summary":"2024年10月09日早盘10时02分，东瑞制药股票出现波动，股价大幅下跌6.92%。截至发稿，该股报1.210港元/股，成交量57.2万股，换手率0.04%，振幅2.31%。东瑞制药股票所在的药品行业中，整体涨幅为0.17%。其相关个股中，三爱健康集团、培力农本方、康臣药业涨幅较大，振幅较大的相关个股有三爱健康集团、艾美疫苗、华控康泰，振幅分别为32.98%、17.08%、12.50%。成药部从事制造及销售成药业务,包括抗生素制剂药及非抗生素制剂药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100910024598e3b4ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100910024598e3b4ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02348","BK1191"],"gpt_icon":0},{"id":"2473461132","title":"东瑞制药盘中异动 早盘急速跳水6.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473461132","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473461132?lang=zh_cn&edition=full","pubTime":"2024-10-08 10:36","pubTimestamp":1728355013,"startTime":"0","endTime":"0","summary":"2024年10月08日早盘10时36分，东瑞制药股票出现异动，股价急速下跌6.47%。截至发稿，该股报1.300港元/股，成交量3.6万股，换手率0.00%，振幅2.16%。东瑞制药股票所在的药品行业中，整体跌幅为1.45%。其相关个股中，华控康泰、顺腾国际控股、长江生命科技涨幅较大，振幅较大的相关个股有三爱健康集团、艾美疫苗、康龙化成，振幅分别为92.86%、45.18%、32.64%。成药部从事制造及销售成药业务,包括抗生素制剂药及非抗生素制剂药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100810365498e3b114&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100810365498e3b114&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02348","BK1191"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.dawnrays.com","stockEarnings":[{"period":"1week","weight":0.0147},{"period":"1month","weight":0.0615},{"period":"3month","weight":0.2742},{"period":"6month","weight":0.2321},{"period":"1year","weight":0.3503},{"period":"ytd","weight":0.2116}],"compareEarnings":[{"period":"1week","weight":0.0282},{"period":"1month","weight":0.0583},{"period":"3month","weight":0.0921},{"period":"6month","weight":0.1323},{"period":"1year","weight":0.4914},{"period":"ytd","weight":0.2769}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"东瑞制药（控股）有限公司是一家投资控股公司，主要从事非专利药物的开发、制造及销售业务。产品包括中间体、原料药及成药。该公司通过两个业务部门运营。中间体及原料药部从事制造及销售中间体及原料药业务。成药部从事制造及销售成药业务，包括抗生素制剂药及非抗生素制剂药。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.002477},{"month":2,"riseRate":0.454545,"avgChangeRate":-0.00484},{"month":3,"riseRate":0.5,"avgChangeRate":0.021967},{"month":4,"riseRate":0.681818,"avgChangeRate":0.037678},{"month":5,"riseRate":0.5,"avgChangeRate":0.019661},{"month":6,"riseRate":0.590909,"avgChangeRate":0.008578},{"month":7,"riseRate":0.545455,"avgChangeRate":0.019022},{"month":8,"riseRate":0.347826,"avgChangeRate":-0.014797},{"month":9,"riseRate":0.5,"avgChangeRate":0.025785},{"month":10,"riseRate":0.409091,"avgChangeRate":-0.002671},{"month":11,"riseRate":0.545455,"avgChangeRate":0.035529},{"month":12,"riseRate":0.590909,"avgChangeRate":0.014754}],"exchange":"SEHK","name":"东瑞制药","nameEN":"DAWNRAYS PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.7","shortVersion":"4.34.7","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"东瑞制药(02348)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供东瑞制药(02348)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"东瑞制药,02348,东瑞制药股票,东瑞制药股票老虎,东瑞制药股票老虎国际,东瑞制药行情,东瑞制药股票行情,东瑞制药股价,东瑞制药股市,东瑞制药股票价格,东瑞制药股票交易,东瑞制药股票购买,东瑞制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"东瑞制药(02348)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供东瑞制药(02348)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}